Imagion Biosystems is a biotech company aiming to make a difference to the lives of cancer patients, with groundbreaking imaging techniques being trialled in Australian hospitals.
CEO Bob Proulx joins Sean Aylmer from San Diego to talk about Imagion's work, and why they chose to list on the ASX.

Rate hike next week; Middle East embassies shuttered; robotaxis sans steering wheels
17:13

Q+A: Investors lined up to buy gold. This is who they were buying from.
11:41

Afternoon Report | ASX rises, Scott Morrison cleared
05:23